Answers are grounded in this paper and cite their sources.
Several organisations have recommended greatly expanded screening for hepatitis C infection. Ronald Koretz and colleagues are concerned that no study has tested whether this will lead to net clinical benefit or harm in screened populations
No takes yet. Share an insight, caveat, or question.
Koretz et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: